Short- and Long-Term Clinical Outcomes in Rhesus Monkeys Inoculated with a Highly Pathogenic Chimeric Simian/Human Immunodeficiency Virus

Antzeko izenburuak

• Early Control of Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys Usually Results in Long-Lasting Asymptomatic Clinical Outcomes
  nork: Igarashi, Tatsuhiko, et al.
  Argitaratua: (2003)
• CD8(+) and CD20(+) Lymphocytes Cooperate To Control Acute Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys: Modulation by Major Histocompatibility Complex Genotype
  nork: Mao, Hanwen, et al.
  Argitaratua: (2005)
• Rapid and Irreversible CD4(+) T-Cell Depletion Induced by the Highly Pathogenic Simian/Human Immunodeficiency Virus SHIV(DH12R) Is Systemic and Synchronous
  nork: Igarashi, Tatsuhiko, et al.
  Argitaratua: (2002)
• Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic
  nork: Imamichi, Hiromi, et al.
  Argitaratua: (2002)
• Determination of a Statistically Valid Neutralization Titer in Plasma That Confers Protection against Simian-Human Immunodeficiency Virus Challenge following Passive Transfer of High-Titered Neutralizing Antibodies
  nork: Nishimura, Yoshiaki, et al.
  Argitaratua: (2002)